CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
Faroogh Marofi(Tabriz University of Medical Sciences), Farhad Motavalli Khiavi(Pasteur Institute of Iran), Moaed E. Al‐Gazally(University of Kerbala), Walid Kamal Abdelbasset(Prince Sattam Bin Abdulaziz University), Marwan Mahmood Saleh(University of Anbar), Roza Motavalli(Tabriz University of Medical Sciences), Marzieh Nikoo(Kermanshah University of Medical Sciences), Ali Hassanzadeh(Iran University of Medical Sciences), Adel Naimi(Sabzevar University of Medical Sciences), Mahboubeh Yazdanifar(Stanford University), Yashwant Pathak(University of South Florida), Lakshmi Thangavelu(Saveetha University), Wanich Suksatan(UCLouvain Saint-Louis Brussels), Heshu Sulaiman Rahman(University of Sulaimani), Behzad Baradaran(Tabriz University of Medical Sciences), Alexei Valerievich Yumashev(Sechenov University)
Cited by 76
Related Papers
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
|Frontiers in Pharmacology|2018|1.1k
CAR T cells in solid tumors: challenges and opportunities
|Stem Cell Research & Therapy|2021|573
Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
|Stem Cell Research & Therapy|2022|404
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275
RETRACTED ARTICLE: A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
|Journal of Translational Medicine|2021|204